These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23672597)

  • 1. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
    Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
    BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of Jiangtang Xiaozhi Capsule in treating type 2 diabetes mellitus patients].
    Chen ZH; Xia CD; Wei ZX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jul; 32(7):910-3. PubMed ID: 23019945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
    Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM
    Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
    Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ayurvedic Herbal Preparation Supplementation Does Not Improve Metabolic Health in Impaired Glucose Tolerance Subjects; Observations from a Randomised Placebo Controlled Trial.
    Esser D; Matualatupauw J; de Vos RCH; Wehrens R; van der Stappen J; van der Meer I; Afman LA
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 11. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.
    Halpern A; Mancini MC; Suplicy H; Zanella MT; Repetto G; Gross J; Jadzinsky M; Barranco J; Aschner P; Ramirez L; Matos AG
    Diabetes Obes Metab; 2003 May; 5(3):180-8. PubMed ID: 12681025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
    Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
    Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.
    Klupp NL; Chang D; Hawke F; Kiat H; Cao H; Grant SJ; Bensoussan A
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007259. PubMed ID: 25686270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Punthanitisarn S
    J Clin Pharm Ther; 2016 Apr; 41(2):180-8. PubMed ID: 27009750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abscisic Acid Treatment in Patients with Prediabetes.
    Derosa G; Maffioli P; D'Angelo A; Preti PS; Tenore G; Novellino E
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32987917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.
    Panigrahi A; Mohanty S
    BMC Endocr Disord; 2023 Sep; 23(1):190. PubMed ID: 37679692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial.
    Wang TZ; Chen Y; He YM; Fu XD; Wang Y; Xu YQ; Yang HJ; Xue HL; Liu Y; Feng XT; Zhang T; Wang WJ
    J Integr Med; 2013 May; 11(3):175-83. PubMed ID: 23743161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.